Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204737 · ClinicalTrials.gov registry record · Phase 4
Short Course Glucocorticoid Treatment for PTSD
A Phase 4 study of Post Traumatic Stress Disorder, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT00204737: Completed Phase 4 study of Post Traumatic Stress Disorder, sponsored by University of Wisconsin, Madison.
NCT00204737 is a Phase 4 study of Post Traumatic Stress Disorder that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00204737, a Phase 4 study of Post Traumatic Stress Disorder, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo
Primary Outcome
This measure tests the hypothesis that there will be a 30% or greater improvement in the Clinician-Administered PTSD (Post Traumatic Stress Disorder) Scale over the course of the study. CAPS is a 30-item survey with a total possible range of scores from 0-120 where the higher the score, the more severe the symptoms.
Conditions Studied
Interventions
- DRUG placebo
- DRUG prednisone
Study Locations (2)
Wisconsin
- Catherine Johnson - Madison
- Wm. S. Middleton VA Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
What the finished NCT00204737 record still lists
NCT00204737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00204737 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00204737 about?
NCT00204737 is a clinical study titled "Short Course Glucocorticoid Treatment for PTSD". The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo
What is the current status of trial NCT00204737?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2004-12. Estimated completion is 2009-01.
What conditions does trial NCT00204737 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT00204737?
The interventions under investigation include: placebo (DRUG), prednisone (DRUG).
Who is sponsoring clinical trial NCT00204737?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00204737 being conducted?
This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00204737's enrollment target sits among peer trials
12 248th of 262 higher than 14 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder
RECRUITING · Phase 4
-
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
RECRUITING · Phase 4
-
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
ACTIVE NOT RECRUITING · Phase 4
-
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
COMPLETED · Phase 4
-
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
COMPLETED · Phase 4
-
A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia